Swiss pharmaceutical firm Novartis and computer giant Microsoft have signed a five-year partnership deal aimed at transforming the Basel-based pharma’s business - from finance to manufacturing - using artificial intelligence.
This content was published on
1 minute
Keystone-SDA/sb
The new Novartis AI innovation lab, with Microsoft as its strategic AI and data-science partner, aims to “significantly bolster Novartis AI capabilities from research through commercialization and help accelerate the discovery and development of transformative medicines for patients worldwide”, the two firms said in a statement on TuesdayExternal link.
Joint research activities will be carried out at the Novartis Campus in Basel, Switzerland, at the Novartis Global Service Center in Dublin, Ireland, and at the Microsoft Research Lab in Cambridge, Britain.
They hope to start focusing on personalized therapies for macular degeneration, cell & gene therapies and drug design.
Novartis Chief Executive Officer Vas Narasimhan said, “As Novartis continues evolving into a focused medicines company powered by advanced therapy platforms and data science, alliances like this will help us deliver on our purpose to reimagine medicine to improve and extend lives. Pairing our deep knowledge of human biology and medicine with Microsoft’s leading expertise in AI could transform the way we discover and develop medicines for the world.”
More
More
The pharma holy grail: drugs for you, designed by you
This content was published on
In the age of sensors, wearables, and artificial intelligence (AI), almost everything can be customised for the individual.
Has your continent reached its peak or is there still potential for economic growth?
Some regions of the world are on an upward trajectory with the promise of a steadily improving future. Where do you live? And in which direction is your region or continent developing?
Swiss president kicks off National Day celebrations on Rütli meadow
This content was published on
Several hundred people gathered on the Rütli in central Switzerland at midday on Friday to celebrate the national Swiss holiday, before Karin Keller-Sutter addressed the crowd.
US sets deadline for Novartis and other pharma firms to lower prices
This content was published on
US President Donald Trump says he has sent letters to Swiss giant Novartis and other pharma firms calling for lower drug prices in the United States – or face retaliation.
Around 25,000m3 of rockfall registered in Swiss village of Brienz
This content was published on
More rock has come loose in the eastern Swiss village of Brienz than initially assumed following rainfall last weekend, said a new situation report published on Friday.
Swiss government reacts with ‘great regret’ to new US tariffs
This content was published on
The Swiss government says it will continue to strive for a negotiated solution after the United States imposed 39% tariffs on the Alpine country.
Switzerland testing AI tools to make scarecrows more effective
This content was published on
The Swiss agricultural research centre Agroscope is testing an AI system to more effectively prevent damage to agricultural crops caused by crows and rooks.
UN in Geneva calls for reform of tariffs on plastics
This content was published on
The United Nations is calling for a reform of customs tariffs on plastics, which are lower than those imposed on alternatives, ahead of negotiations for a treaty to limit plastic pollution.
Two robots play hide-and-seek in space with Swiss help
This content was published on
Robots developed separately have worked together at the International Space Station (ISS) for the first time, helped in part by a control centre in Switzerland.
Giant Swiss flag torn by the wind at the foot of mountain
This content was published on
A giant Swiss flag tore as it was rolled out on a grassy slope at the foot of a mountain ahead of August 1 National Day celebrations.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Novartis rejects suspected data manipulation in US
This content was published on
Swiss pharma giant Novartis has dismissed criticism that it allegedly withheld information about animal testing data inaccuracies to US authorities.
WHO adopts watered-down resolution on drug transparency
This content was published on
The World Health Organization (WHO) has adopted a resolution to improve transparency on drug prices but some people say it doesn't go far enough.
This content was published on
Swiss pharmaceutical Novartis must face a US government lawsuit accusing it of paying millions of dollars in kickbacks to doctors.
The pharma holy grail: drugs for you, designed by you
This content was published on
In the age of sensors, wearables, and artificial intelligence (AI), almost everything can be customised for the individual.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.